You are on page 1of 10

TTK Healthcare

LIM ITE D
May 30, 2016

TTKH:SECL:GJ:076:16
BSE Limited

Phiroze JeejeebhoY Towers


25s Floor, DalalStreet

Mumbai 400 001


Company Code :
Scrip Code :

53
507747

31

Dear Sirs,

Re

Audited Financial Results forthe vear ended 31st March. 2016

We are forwarding herewith the Audited Financial Results for the year ended 31stMarch,2016,
Board of Directors of
along with the Audit Report, Form A and Declaration taken on record by the
the Company at their Meeting held today at Chennai'
Kindly take the above document on record.

Thanking you

Yours faithfullY

For TTK Healthcare Limited

@ry
(S KALYANARAMAN)
Director t Wholetime Secretary

Encl.

a/a

Regd. Office : No. 6, Cathedral Road, Chennai- 600 086, INDIA


Phone : 91 44-281 16 1 06 - 08, F ax : 9 1 -44-281 1 6387

Email : info@ttkhealthcare.com Website : wwwttkhealthcare.com


CIN : 124231TN1 958PLC003647

(Factory: 5, Old Trunk Road, Pallavaram Chennai - 600 043, INDIA)

&

TTK HEALTHCARE LIMITED


Regd. Oftlco : No.6, Cathsdral Road, Chennal 600 086
CIN: L24231TN'1958PLC0036,U Website: www.ttkhealthcars.com

STATEMENT OF AUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED

3tst MARCH,2O16
(Rs. in lakhs)

3 months

sl.

Particulars

No

ended

Corresponding 3
Preceding 3
months
Current Year Previous
months
Year ended
ended in the
ended
ended
previous
year
(31t12120151

Unaudited

Unaudited

EI

(31/03/20't 5) (31/03/2016)

Unaudited

Audited

(31/03/2015)

Audited

lncome from Operations


(a) Net Sales / lncome from Operations
(Net of Excise Duty)
(b) Other Operatinq lncome

11956.76

12682.63

11169.66

51480.01

48254 73

3.44

Total income from Operations (Net)

395.42
13078.05

20.35
11190.01

406.54
51886.55

37.93
48292.66

864.48
4602.53

703.45
4214.03

3547 .32

4703.78

19525.48

3138.64
19063.03

-472.26

196.01

14.02

-145.66

-256.89

2124 46
265.35
1182.43
2334.84
11163.61

2038.9s
146.08
1925.65
2196.54
11970.24

1899.30
247 22
1355.70
2102.47
10535.19

u79.A7
7685.67
9046.90
48560.29

7228.44
613.98
7961.59
8202.96
45951.75

796.59

1107.8'1

653.82

3326.26

2340.9',1

160.52

124.94

201.40

Finance Costs and Exceptional ltems (3t4)

957.',1l

1232.75

855.22

Finance Costs

114 14

71

Profit / (Loss) from Ordinary Activltles after


Finance Costs but before Excsptional ltems

842.97

1161.66

758.85

3552.7 4

2633.46

0.00

0.00

0.00

0.00

000

842.97

'1161.66

758.85

3552.74

2633.46

302.05

1286.22

1017.94

I
I

(31/03/2016)

Expenses
(a) Cost of materials consumed
(b) Purchases of Stock-in-trade
(c) Changes in lnventories of finished goods, workin-progress and stock-in-trade
(d) Emplovee benefits exDense
(e) Deprecration and amortisation expense
(f) l\,4arketino Expenses
(q) Other expenses

Total Expenses
Profit / (Loss) from Operations before Other
lncome, Finance Costs and Exceptional ltems

r960.20
1025.O1

720.71

11-21

4
5

Other lncome
Profit / (Loss) from Ordinary Activities before

656.78
3885.47

.09

2997.69
364 23

(5i6)
B

10
11

12
13
14
16

Exceptional ltems

Profit / (Loss) from Ordinary Activitles before


Tax (718)
Tax Expense
Net Profit / (Loss) from Ordinary Activities after
Tax (9t10)
Extraordinary ltems (Net of Tax Expenses)
Net Profit / (Loss) for the perlod (1M2)
Share of Profit / (Loss) of Associates
Minority lnterest
Net Profit / (Loss) after taxes, minority interest
and share of prolit / (loss) of associates

(13r14r15)

248.70
594.27

729,'t'l

456.80

2266.52

1615.52

0.00
594.27

0.00
729.',|1

0.00
456.80

0.00
2266.52

1515.52

N,A.

N,A.

N.A.

N,A,

N,A.

N,A.

594.27

729.1',|

456.80

000
N,A.

r,l.A.

2266.52

N,A

1615.52

17
1B

Paid-up Equity Sh are Capital (Face Value Rs.10/per share)


Reserve excluding Revaluation Reserves as per
Balance Sheet of previous accounting year

19

Earnlngs per sharo (before Extraordinary ltems)

(i)

{of Rs.10/. each) (not annualised):


1a)

Basic

(b) Oiluted
19
(

ii)

776.60

776.60

776.60

776.60

12403 18

10604.00

7.65

5.88

765

588

29.19
29.19

20.80
20.80

5.88

29.19

s.88

10

20 80
20.80

Earnings per share (after Extraordinary ltems)


(of Rs.10/. each) (not annualised):
(a) Basic
(b) Diluted

776.60

7.65
7.65

9.39
9.39

,o

NqIES;

The above results have been reviewed / audited by the Statutory Auditors of the Company, reviewed by the Audit Committee
and approved by the Board of Directors of the Company at their Meeting held on 30th May, 2016, at Chennai.

(2)

The Other Operating lncome for the current year includes non-recurring income of Rs.3.25 crores (Net) received during the
Third Quarter towards product development trials conducted for a Third Party.

(3)

The Board has recommended a Dividend ofRs.5.00per Equity ShareofRs.l0/- each (50%) forthe financial yearended3lst

(1

March.2016.

(4)

The figures for the three months' ended 3'1st lMarch, 2016 are the balancing figures betlveen the audited figures in respect of
the full flnancial year and the published year to date figures upto the nine months of the relevant financial year

(5) The previous

period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current
period's / yea/s presentation.

(6) This

Statement is also available on the website of BSE Limited (www.bseindia.com) and National Stock Exchange of lndia
Limited (www. nseindia.com) and also on the website of the Company (www.ttkhealthcare.com).

17l Standalone Sta temont

of Assets and Liabllities as at 31st March, 20i6:

st.

Particula rs

No.

EQUITY AND LIABILITIES

Shareholde6' Funds
(a) Share Capital
(b)

Reserves and Surplus

(c) Money received against Share Warrants


Sub-Total . ShareholderB' Funds
2

Share Application Money pendlng allotment

Minority lnterest
4. Non.Current Liabilities
3

77659830

77659830

1284460632

1105045079

1362120462

1182704909

Long-Term Borrowings

10609632

159836379

Deferred Tax Liabilities (Net)

50680409

22258779

102451721

96564362

Long-Term Provisions

163741762

278659520

(a) Short-Term Borrowings

219531330

223012201

(b) Trade Payables

3337 40251

300688951

(c) Other Current Liabilities

899302473

724732163

46839759

42166265

r499413813

1290599580

3025276037

275r964009

Sub.Total - Non-Current Llabilities


Current Liabilities

(d) Short-Term Provisions

Sub-Total Current Liabilities


-

TOTAL - EQUITY AND LIABILITIES


1

Rs.

(b)
(d)

As at 31/03/2015

Rs.

(a)

(c) Other Long-Term Liabilities

5.

As at 31/03/2016

ASSETS

Non-Current Assets
(a) Fixed Assets

1070704147

97

5720790

(b) Goodwill on Consolidation

(c) Non-Current lnvestments


(d) Deferred Tax Assets (Net)

118926017

115245388

(e) Long-Term Loans and Advances

(0

Other Non-Current Assets

Sub.Total - Non-Current Assets

1'189630124

1090956'178

Current Assets
(a) Current lnvestments

101337000

1337000

(b) lnventories

414526066

37377 437 5

(c) Trade Receivables

466202804

444125976

(d) Cash and Cash Equivalents

771629049

772998464

81951034

68762016

1835645913

1660997831

302s276037

2751964009

(e) Short-Term Loans and Advances

(0

Other Current Assets

Sub-Total - Current Assets


TOTAL . ASSETS

For TTK H e

Place:

Chennai

Date:

May 30, 2016

Lfy*t'"neo

T T RAGHUNATHAN
EXECUTIVE VICE CHAIRMAN

&

TTK HEALTHCARE LIMITED


REgd,

Offico

No,6, Cathedral Road, Chennat 600 086

CIN: L24231TN1958PLC003647 Wsbslto: www.ttkheatthcare.com

SEGMENTWISE REVENUE, RESULTS & CAPITAL EMPLOYED


Rs. in lakhs

3 months

st.

Particula rs

No

ended

Correspondlng 3
Previous 3
months
Current year Previous
months
ended ln the
ended
Y6ar ended
6nded
previous
year

lE?rEnr,lEllE[@El
Unaudited
,|

S
a
b

c
d
e

c
e

Total Profit (+) / Loss (-) before tax

a
b

c
d

e
Total Ca

Add

dinS

't485.06

'1436.95

836

13.11

12682.63

'H169.66

000

0.00
11169.66

832 52

ments

Unallocable Corporate Assets lggg


Unallocable C
orate Liabilities
Total Ca ital Em
d in Com

750.10

lElr,E77,lHlE'rfillfEl

IME?F.IIIIIIMIiI

157.75

186.58

842.97

1161.66

31/03/2016
-84.67
1457.55
-380.24
9634.58
-39.08

As on
31t12t20't5
478.72

165.39
758.

As on
3t/03/2015

@39
reEIU

I@EI@

3117 82
393.43
1 15.64
915.63
31.89

688.94
3552.7

As on

26275.27
1979.64
5712.28

2510.23
301.89
-543.65
1236.83
26.25
3531.55
364 23
533.86
2633.46

As on
31t0312015
1048.98
1228.77

9704.46

31to3t2o',t6
-84.67
1457 .55
-380.24
9634.58
-39.08
10588.14

1048.98

'1'186.33

-124.86

2766s.54
2251.06

457 4.41

-IEEE@re
As on

ment Liabilities

Pharmaceuticals
l\,4ed cal Devices
Consumer Products
Foods
Others

ital E

6119.70
468.26

12682.63

880.67

Net of Unallocable lncome

Capital Employed
ment Assets - S

11956.76

6702 B5
496.73

r@rcre
rerc-EE
rereETg
reEE,re
III@IE@I@

Pharmaceuticals
Medical Devices
Consumer Products
Foods
Others

Total
Less : lnterest
Less : Unallocable Expenses

J.

Unaudited

re
@-r.r{rflEE[[IEr,r,6!@@l
I@
@
rc
re
II@
E!@@
re
rcre
E!@@
6260.29

31103t201s

ent Revenue:
Pharmaceuticals
lredical Devices
Consumer Products
Foods
Others

Total
Less : lnter S ment Revenue
Net Sales / lncome from
tions
Segment Results: lProflt (+) / Loss (-)
before tax and lnterest from each
a
b

Unaudited

-253.16

-253.'16

7700.97
-21.10
9704.46

6221.81

6342 02

6782.55

6221 .81

6782.55

16809.9s

16381.67

16487.01

16809.95

16487.01

NOIEST

1.

Segments have been identified in line with the Accounting Standard on Segment Reporting (AS-17) considering th
organisation structure and the differential risks and returns of these segments.

Segment Sales is net of Excise Duty related to the Sales of own manufactured goods for the current as well as fo
the previous periods.

3.

Details of products included in each of the Segments are as below

Pharmaceuticals include products for both Human and Veterinary

use. lt also includes OTC Brands

Woodward's Gripewater distributed by the Consumer Products Oivision.

*
,l
a
*

Medical Devices include Artificial Heart Valves, Orthopaedic lmplants, etc.

Consumer Products comprise of marketing and distribution of EVA Range of Cosmetics, Good Home range
Scrubbers, Air Freshners, etc., (Own Brands) and also trading of Branded Condoms.
Foods comprise of manufacturing and marketing of Food Products.
"Others" include Printing and Publashing of Maps and Atlases.

The segment-wise revenue, results and capltal employed figures relate to respective amounts directly identifiabl
each of the segments. The unallocable expenditure includes expenses incurred on common services at
corporate level and also those expenses not identiflable to any specific segment.

The previous period's / yeafs figures have been regrouped and reclassified, wherever necessary to conform to the
current period's / yeals presentation.

For TTK HEALTHCARE LIMITED

{
Place: Chennai

Oate

: Ma 30 2016

T T RAGHUNATHAN
EXECUTIVE VICE CHAIRMAN

INDEPENOENT AUDITORS
REPORT TO THE BOARD OF OIRECTORS OF TTK HEALTHCARE LIMITED
1

We have audited the accompanying Statement of Financial Results of TTK Healthcare


Limited ("the Company") for the year ended 3'l si March, 2016 ("the Statement"), being
submitted by the Company pursuant to the requirement of Regulation 33 of the Securities
and Exchange Board of lndia (Listing Obligations and Disclosure Requirements) Regulations,
2015 ["the SEBI (LOOR) Regulations, 2015"]. This Statement, which is the responsibitity of
the Company's Management and approved by the Board of Directors, has been prepared on
the basis of the related financial statements, which is in accordance with the Accounting

Standards prescribed under Section 133 of the Companies Act, 2013, as applicable and
other accounting principles generally accepted in lndia. Our responsibility is to express an
opinion on the Statement.
2

We conducted our audit in accordance with the Standards on Audating issued by the lnstitute
of Chartered Accountants of lndia. Those Standards require that we comply with ethical
requirements and plan and perform the audit to obtain reasonable assurance about whether
the Statement is free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and the
disclosures in the Statement. The procedures selected depend on the auditor's judgement,
including the assessment of the risks of material misstatement of the Statement, whether due
to fraud or error. ln making those risk assessments, the auditor considers internal control
relevant to the Company's preparation and fair presentation of the Statement in order to
design audit procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Company's internal control. An audit also

includes evaluating the appropriateness

of the

accounting policies used and the

reasonableness of the accounting estimates made by the Management, as well as evaluating


the overall presentation of the Statement.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide
a basis for our audit opinion.
3.

ln our opinion and to the best of our information and according to the explanations given to
us, the Statement, read with Note 4:

(i)

is presented in accordance with the requirements of Regulation 33 of the SEBI (LODR)

Regulations, 2015; and

(ii)

gives a true and fair view in conformity with the aforesaid Accounting Standards and
other accounting principles generally accepted in lndia of the net profit and other
financial information of the Company for the year ended 31"i March, 2016
:\

%*o

vt,

I'

oG.ilMl
600

m4

DAC

This Statement includes the results for the Quarter ended 3lstMarch, 2016 being the
balancing figure between audited figures in respect of the full financial year and the
published year to date figures up to the Third Quarter of the current financial year
which were
subject to limited review by us.

For M/s Aiyar & Co.

Chartered Accountants

F.R. No.000063S

F.R. No.0047705I s2000?5

C--t" (

gr) r

N SRIDHARAN

PROPRIETOR
Mem
Place
Date

For M/s S Viswanathan LLP

Chartered Accountants

C N SRINIVASAN
PARTNER
Membership No.18205

Ghennai
May 30, 2016

ot*{Al
G00

00r

TTK Healthcare
LIMITED
FORM A
As per Regulations 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements)
Regulations , 2015
1

Name of the Company

2. Annual Financial Statements for the

TTK Healthcare Limited


31"t March,2016

year ended
3.

Type of Audit Observation

(i) Unmodified
(ii) Matter of Emphasis -

Proposed Scheme of
Amalgamation between M/s TTK Protective
Devices Limited (formerly known as TTK-LlG
Limited) and its Wholly Owned Subsidiary M/s TSL

Techno Services Limited (TSL) [Transferor


Companiesl with the Company [Transferee
Companyl
4.

Frequency of Observation

5.

Signed by-

Matter of Emphasis - Fourth time (Since the Merger


is yet to be sanctioned by the Hon'ble High Court
of Judicature at Madras).

k/
I

CEO / Managing Director

(T T RAGHUNATHAN)
Exe cutia e V i ce Ch airman

G .u'f,4'

cFo

(B V K DURGA
Senior Vice President - Finance

Auditors of the Company

(./

(N SRIDHARAN)

Proprietor
na/p

4tyel& 99.

__)

(c N SRTNTVASAN)
Partner
M/s S Viswanathan LLP

Audit Committee Chairman

a,il^, --'ffiEf,(eol
Chairman

Audit Committee
Regd. Office : No. 6, Cathedral Road, Chennai - 600 086' INDIA
Phone :91-44-28116106 - 08, Fax :9144-28116387

Email : info@ttkhealthcare.com Website : www.ttkhealthcare.com


CIN : 124231 TN1 958P1C003647
(Factory: 5, Old Trunk Road, Pallavaram Chennai- 600 043, INDIA)

tt*
TTK Healthcare
LIfUITED
TTKH:SECL:cJ:078:16

May 30, 2016

BSE Limited

Phiroze Jeeieebhoy Towers


25tn Floor, Dalal Street

Mumbai 400 001


Company Code :
Scrlp
:

Code

3153
5077 47

Dear Sirs,

Sub: Declaration rslating to the Unmodified Opinion by the Statutory


Auditors on the Audited Financial Statements for the year ended 31't
March,2016

Ref:

(i)

Regulation 33(3)(d) totheSEB| (LODR) Regulations, 2015

(ii) Notification dated

25th May,2O16 issued by SEBI

(iii) Circular No.C|R/CFD/CMD/56/2016 dated 27'n May,2O15 issued by


SEBI

We hereby declare that the Statutory Auditors of the Company have given their Unmodified
Opinion to the Audited Financial Statements of the Company for the year ended 31"r lvlarch, 2016.

Their Report also includes an "Emphasis of Matters" relating to the proposed Scheme of
Amalgamation between M/s TTK Protective Devices Limited (formerly known as TTK-LIG Limited)
and its Wholly Owned Subsidiary M/s TSL Techno Services Limited (TSL) [Transferor Companies]
with the Company lTransferee Company] which is awaiting the sanction of the Hon'ble High Court
of Judicature at Madras.
Please take the above information on record.

Thanking you

Yours faithfully
For TTK Hea

ate

ited

(T T RAGHUNATHAN)
V ice Chairman

Execut iz,e

Regd. Office : No. 6, Cathedral Road, Chennai - 600 086, INDIA


Phone : 9144-28'116106 - 08' Fax : 9144-28116387
Email : info@ttkhealthcare.com Website : www.ttkhealthcare com
CIN : L24231TNl 958P1C003647
(Factory : 5, Old Trunk Road, Pallavaram Chennai - 600 043' INDIA)